Literature DB >> 27184442

Versatile theranostics agents designed by coating ferrite nanoparticles with biocompatible polymers.

M Zahraei1, M Marciello, A Lazaro-Carrillo, A Villanueva, F Herranz, M Talelli, R Costo, A Monshi, D Shahbazi-Gahrouei, M Amirnasr, B Behdadfar, M P Morales.   

Abstract

Three biocompatible polymers, polyethylene glycol (PEG), dextran and chitosan, have been used in this work to control the colloidal stability of magnetic nanoparticles (14 ± 5 nm in diameter) and to vary the aggregation state in order to study their effect on relaxometric and heating properties. Two different coating strategies have been deeply developed; one based on the formation of an amide bond between citric acid coated nanoparticles (NPs) and amine groups present on the polymer surface and the other based on the NP encapsulation. Relaxometric properties revealed that proton relaxation rates strongly depend on the coating layer hydrophilicity and the aggregation state of the particles due to the presence of magnetic interactions. Thus, while PEG coating reduces particle aggregation by increasing inter-particle spacing leading to reduction of both T1 and T2 relaxation, dextran and chitosan lead to an increase mainly in T2 values due to the aggregation of particles in bigger clusters where they are in close contact. Dextran and chitosan coated NPs have also shown a remarkable heating effect during the application of an alternating magnetic field. They have proved to be potential candidates as theranostic agents for cancer diagnosis and treatment. Finally, cytotoxicity of PEG conjugated NPs, which seem to be ideal for intravenous administration because of their small hydrodynamic size, was investigated resulting in high cell viability even at 0.2 mg Fe ml(-1) after 24 h of incubation. This suspension can be used as drug/biomolecule carrier for in vivo applications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27184442     DOI: 10.1088/0957-4484/27/25/255702

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  6 in total

Review 1.  Recent advances in the preparation and application of multifunctional iron oxide and liposome-based nanosystems for multimodal diagnosis and therapy.

Authors:  Marzia Marciello; Juan Pellico; Irene Fernandez-Barahona; Fernando Herranz; Jesus Ruiz-Cabello; Marco Filice
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

2.  Synthesis and characterisation of iron oxide nanoparticles conjugated with epidermal growth factor receptor (EGFR) monoclonal antibody as MRI contrast agent for cancer detection.

Authors:  Zeinab Salehnia; Daryoush Shahbazi-Gahrouei; Abolfazl Akbarzadeh; Behzad Baradaran; Safar Farajnia; Mehran Naghibi
Journal:  IET Nanobiotechnol       Date:  2019-06       Impact factor: 1.847

3.  In vitro Study of SPIONs-C595 as Molecular Imaging Probe for zzm321990Specific Breast Cancer (MCF-7) Cells Detection

Authors:  Pegah Moradi Khaniabadi; Daryoush Shahbazi-Gahrouei; Amin Malik Shah Abdul Majid; Mohammad Suhaimi Jaafar; Bita Moradi Khaniabadi; Saghar Shahbazi-Gahrouei
Journal:  Iran Biomed J       Date:  2017-06-11

4.  Assessment of Manganese-Zinc Ferrite Nanoparticles as a Novel Magnetic Resonance Imaging Contrast Agent for the Detection of 4T1 Breast Cancer Cells.

Authors:  Tayebe Sobhani; Daryoush Shahbazi-Gahrouei; Mahboubeh Rostami; Maryam Zahraei; Amin Farzadniya
Journal:  J Med Signals Sens       Date:  2019-10-24

5.  In vivo study of anti-epidermal growth factor receptor antibody-based iron oxide nanoparticles (anti-EGFR-SPIONs) as a novel MR imaging contrast agent for lung cancer (LLC1) cells detection.

Authors:  Daryoush Shahbazi-Gahrouei; Negar Abdi; Saghar Shahbazi-Gahrouei; Seyed Hossein Hejazi; Zeinab Salehnia
Journal:  IET Nanobiotechnol       Date:  2020-07       Impact factor: 1.847

Review 6.  Theranostics Based on Magnetic Nanoparticles and Polymers: Intelligent Design for Efficient Diagnostics and Therapy.

Authors:  Andrew J Gauger; Kian K Hershberger; Lyudmila M Bronstein
Journal:  Front Chem       Date:  2020-07-07       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.